Flavonoids appear to be significant anti-cancer agents by targeting receptor tyrosine kinases (RTKs) and influencing their downstream signaling pathways, such as MAPK, PI3K/Akt, and JAK/STAT [104]. Here, AKT1 is linked to cancer.